rs114688446

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001366385.1(CARD14):​c.599G>A​(p.Ser200Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00739 in 1,563,970 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S200I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0059 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0076 ( 68 hom. )

Consequence

CARD14
NM_001366385.1 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -0.279

Publications

10 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
CARD14 Gene-Disease associations (from GenCC):
  • familial pityriasis rubra pilaris
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • psoriasis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003829211).
BP6
Variant 17-80184162-G-A is Benign according to our data. Variant chr17-80184162-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 68785.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00594 (904/152274) while in subpopulation NFE AF = 0.00879 (598/68016). AF 95% confidence interval is 0.00821. There are 6 homozygotes in GnomAd4. There are 429 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 904 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.599G>A p.Ser200Asn missense_variant Exon 7 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.599G>A p.Ser200Asn missense_variant Exon 7 of 24 NM_001366385.1 ENSP00000498071.1

Frequencies

GnomAD3 genomes
AF:
0.00595
AC:
905
AN:
152156
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.00517
Gnomad ASJ
AF:
0.0141
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00766
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00879
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.00640
AC:
1095
AN:
171110
AF XY:
0.00677
show subpopulations
Gnomad AFR exome
AF:
0.00120
Gnomad AMR exome
AF:
0.00232
Gnomad ASJ exome
AF:
0.0194
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00518
Gnomad NFE exome
AF:
0.00788
Gnomad OTH exome
AF:
0.00601
GnomAD4 exome
AF:
0.00755
AC:
10661
AN:
1411696
Hom.:
68
Cov.:
31
AF XY:
0.00766
AC XY:
5345
AN XY:
697442
show subpopulations
African (AFR)
AF:
0.000897
AC:
29
AN:
32334
American (AMR)
AF:
0.00224
AC:
83
AN:
37022
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
487
AN:
25226
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36964
South Asian (SAS)
AF:
0.00821
AC:
657
AN:
79976
European-Finnish (FIN)
AF:
0.00551
AC:
273
AN:
49578
Middle Eastern (MID)
AF:
0.00762
AC:
43
AN:
5646
European-Non Finnish (NFE)
AF:
0.00787
AC:
8547
AN:
1086424
Other (OTH)
AF:
0.00926
AC:
542
AN:
58526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
578
1155
1733
2310
2888
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00594
AC:
904
AN:
152274
Hom.:
6
Cov.:
33
AF XY:
0.00576
AC XY:
429
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41556
American (AMR)
AF:
0.00516
AC:
79
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0141
AC:
49
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00746
AC:
36
AN:
4826
European-Finnish (FIN)
AF:
0.00518
AC:
55
AN:
10624
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00879
AC:
598
AN:
68016
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
45
91
136
182
227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00650
Hom.:
3
Bravo
AF:
0.00544
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00675
AC:
26
ExAC
AF:
0.00473
AC:
558

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CARD14: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
UniProtKB/Swiss-Prot
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Mar 05, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.028
DANN
Benign
0.20
DEOGEN2
Benign
0.0048
T;T;.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0072
N
LIST_S2
Benign
0.55
.;.;T;T
MetaRNN
Benign
0.0038
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.025
N;N;N;N
PhyloP100
-0.28
PrimateAI
Benign
0.44
T
PROVEAN
Benign
1.3
.;.;.;N
REVEL
Benign
0.019
Sift
Benign
1.0
.;.;.;T
Sift4G
Benign
1.0
T;.;T;T
Polyphen
0.0
B;B;.;B
Vest4
0.044
MVP
0.40
MPC
0.14
ClinPred
0.00079
T
GERP RS
-3.7
Varity_R
0.033
gMVP
0.043
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114688446; hg19: chr17-78157961; API